Clinical research on prediction marker of efficacy in advanced non-small cell lung cancer / 肿瘤研究与临床
Cancer Research and Clinic
; (6): 581-584, 2010.
Article
in Zh
| WPRIM
| ID: wpr-383366
Responsible library:
WPRO
ABSTRACT
Individualized therapy is the current trend of treatment in advanced non-small cell lung cancer, the key of individualized therapy is to administrer different treatment options through different biological markers or clinical markers. Currently, biological markers include EGFR protein expression, EGFR mutations, EGFR gene copy, k-ras mutation, EML4-ALK gene fusion, C-MET gene. Clinical markers include rash, pathological types, etc. This article will give a review about those biomarkers.
Full text:
1
Database:
WPRIM
Type of study:
Prognostic_studies
Language:
Zh
Journal:
Cancer Research and Clinic
Year:
2010
Document type:
Article